T36.7X5

Clinical Causes: Use of systemic antifungal antibiotics such as amphotericin B, fluconazole, itraconazole, voriconazole, or posaconazole. Prolonged therapy with antifungal agents increasing the risk of side effects. Pre-existing health conditions that may predispose individuals to adverse reactions, such as kidney or liver impairment. Individual differences in drug metabolism and genetic factors leading to increased susceptibility.

Key Symptoms: Nausea and vomiting Abdominal pain or discomfort Liver enzyme elevation indicating potential hepatotoxicity Kidney dysfunction symptoms like decreased urine output or swelling Skin reactions such as rash, itching, or hives Electrolyte disturbances, including low potassium or magnesium levels Central nervous system effects like headache, dizziness, or visual changes Hematologic issues such as anemia or leukopenia

Diagnosis Path: Diagnosing adverse effects involves a combination of patient history, clinical examination, and laboratory tests. Healthcare providers may monitor liver and kidney function through blood tests, complete blood counts, and electrolyte panels. Imaging or additional diagnostics might be employed if organ-specific toxicity is suspected. It is crucial to distinguish adverse drug reactions from other underlying health issues to ensure appropriate management.

Treatment Protocols: Management of adverse effects includes stopping or adjusting the antifungal medication, providing supportive care to alleviate symptoms, and treating any organ-specific toxicity. For example, liver or kidney impairment may require specific interventions or medication adjustments. In some cases, alternative antifungal therapies with fewer side effects might be considered. Regular monitoring during treatment helps detect adverse effects early and ensure patient safety.